These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 26194194)
21. mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests. Lainiola M; Procaccini C; Linden AM Behav Brain Res; 2014 Jun; 266():94-103. PubMed ID: 24631392 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological approaches to animal models of human working memory and shifting attentional set. Commentary on Robbins' homology in behavioural pharmacology: an approach to animal models of human cognition. Kesner RP; Ragozzino M Behav Pharmacol; 1998 Nov; 9(7):521-4. PubMed ID: 9862076 [No Abstract] [Full Text] [Related]
23. The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models. Shiraishi E; Suzuki K; Harada A; Suzuki N; Kimura H J Pharmacol Exp Ther; 2016 Mar; 356(3):587-95. PubMed ID: 26675680 [TBL] [Abstract][Full Text] [Related]
24. Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test. Lapiz MD; Bondi CO; Morilak DA Neuropsychopharmacology; 2007 May; 32(5):1000-10. PubMed ID: 17077810 [TBL] [Abstract][Full Text] [Related]
25. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. Rezvani AH; Caldwell DP; Levin ED Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917 [TBL] [Abstract][Full Text] [Related]
26. The synergy of working memory and inhibitory control: behavioral, pharmacological and neural functional evidences. Grégoire S; Rivalan M; Le Moine C; Dellu-Hagedorn F Neurobiol Learn Mem; 2012 Feb; 97(2):202-12. PubMed ID: 22197651 [TBL] [Abstract][Full Text] [Related]
27. The ultimate intra-/extra-dimensional attentional set-shifting task for mice. Scheggia D; Bebensee A; Weinberger DR; Papaleo F Biol Psychiatry; 2014 Apr; 75(8):660-70. PubMed ID: 23810621 [TBL] [Abstract][Full Text] [Related]
29. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092 [TBL] [Abstract][Full Text] [Related]
30. Cognitive impairment in patients clinically recovered from central nervous system depressant drug overdose. Dassanayake TL; Michie PT; Jones A; Carter G; Mallard T; Whyte I J Clin Psychopharmacol; 2012 Aug; 32(4):503-10. PubMed ID: 22722510 [TBL] [Abstract][Full Text] [Related]
31. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure. Enomoto T; Floresco SB Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):668-75. PubMed ID: 19306904 [TBL] [Abstract][Full Text] [Related]
32. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Turner DC; Clark L; Pomarol-Clotet E; McKenna P; Robbins TW; Sahakian BJ Neuropsychopharmacology; 2004 Jul; 29(7):1363-73. PubMed ID: 15085092 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Liu P; Bergin DH Neuroscience; 2009 Mar; 159(3):951-61. PubMed ID: 19356679 [TBL] [Abstract][Full Text] [Related]
34. Effects of melatonin on behavioral changes of neonatal rats in a model of cortical dysplasia. Karadeli HH; Aktekin B; Yilmaz B; Kilic E; Uzar E; Aci A; Bingol CA Eur Rev Med Pharmacol Sci; 2013; 17(15):2080-4. PubMed ID: 23884829 [TBL] [Abstract][Full Text] [Related]
35. Persisting behavioral consequences of prenatal domoic acid exposure in rats. Levin ED; Pizarro K; Pang WG; Harrison J; Ramsdell JS Neurotoxicol Teratol; 2005; 27(5):719-25. PubMed ID: 16054336 [TBL] [Abstract][Full Text] [Related]
36. Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes. Rapport MD; Orban SA; Kofler MJ; Friedman LM Clin Psychol Rev; 2013 Dec; 33(8):1237-52. PubMed ID: 24120258 [TBL] [Abstract][Full Text] [Related]
38. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. Pedersen CS; Goetghebeur P; Dias R J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795 [TBL] [Abstract][Full Text] [Related]
39. Neuropsychological assessment of current and past crack cocaine users. De Oliveira LG; Barroso LP; Silveira CM; Sanchez ZV; De Carvalho Ponce J; Vaz LJ; Nappo SA Subst Use Misuse; 2009; 44(13):1941-57. PubMed ID: 20001290 [TBL] [Abstract][Full Text] [Related]
40. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. Corrales A; Martínez P; García S; Vidal V; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N J Pineal Res; 2013 Apr; 54(3):346-58. PubMed ID: 23350971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]